糖尿病遗传集群和美国印第安人的临床结果
Kaylia M Reynolds1, Quan Sun2,3, Ying Zhang4
1Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.
Diabetes
|August 18, 2025
概括
美国印第安人的遗传分析证实2型糖尿病 (T2D) 是主要的糖尿病类型. 与肥胖和脂质缩相关的特定T2D遗传集群显示与心脏代谢特征的关联,但没有临床结果.
科学领域:
- 遗传学 遗传学 是一个
- 公共卫生 公共卫生
- 代谢疾病 代谢疾病
背景情况:
- 糖尿病是一种严重的公共卫生问题,特别影响美国印第安人群体的高发病率和死亡率.
- 2型糖尿病 (T2D) 的临床异质性需要先进的方法来理解潜在的生物机制.
- 遗传数据为区分糖尿病类型和阐明T2D复杂的病理生理学提供了强大的工具.
研究的目的:
- 在美国印第安人中使用遗传数据区分1型糖尿病 (T1D) 和2型糖尿病 (T2D).
- 通过分析与特定T2D变异相关的遗传集群来确定T2D的生物机制.
- 评估这些遗传集群与心脏代谢特征和临床结果的关联.
主要方法:
- 将T1D多基因分数 (PS) 应用于3084名美洲印第安人 (39%患有糖尿病) 的队列.
- 计算八个T2D相关变异群的分区多基因分数.
- 划分PS和20个心脏代谢特征之间的关联评估,加上五个临床结果.
主要成果:
- 在糖尿病患者中,T1D PS 概况与T2D 相一致.
- 总的T2DPS与T2D发病的早期年龄强烈相关 (P = 3.5 × 10−11).
- 对肥胖和脂质营养不良的分割PST2D集群与特定的心脏代谢特征相关 (例如体脂,甘油三,高密度胆固醇,禁食胰岛素,血压),但没有T2D集群与心血管或结局有关.
结论:
- 研究结果支持T2D作为研究的美洲印第安人队列中占主导地位的糖尿病类型.
- 集群特异性T2D分区PS显示与心脏代谢特征的关系,与其他种群的发现保持一致.
- 通过使用美洲印第安人的遗传变异来改进基因聚类方法,有机会更好地了解T2D机制.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications
687
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
687
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Management and Pharmacotherapy
362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K


